Wells Fargo maintains Ryan Specialty Holdings at Equal-Weight, raises price target to $46 from $41

Wells Fargo kept Ryan Specialty Holdings at Equal-Weight, raising its price target to $46 from $41, implying a 4.9% upside from the last close of $43.84. Recent analyst targets range from $40 to $52.

Original reporting
Published Nov 2, 2026, 1:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 1:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Wells Fargo maintains Ryan Specialty Holdings at Equal-Weight, raises price target to $46 from $41 — source image
Decision brief

The 30-second read

Med
01

Why it matters

The upgrade suggests a modest upside potential, but without fresh earnings data the move may be limited.

02

Market read

A single analyst upgrade with a modest target increase; modest trading relevance.

03

What to watch

No new fundamental data accompanies the target change.

Relevance 6/10Novelty 6/10Timing: today

Background

Analyst price target adjustments are routine but can influence short-term price action.

Market effects

May boost sentiment for specialty insurance sector.

Limited to U.S. market where the stock trades.

Low global relevance.

Counterpoint

The target raise could be premature if underlying earnings remain weak.

Key entities

  • Wells Fargo

    Equity research division raising target.

  • Ryan Specialty Holdings

    Specialty insurance provider.

Related articles

$RYANMed

Ryan Specialty Holdings Inc (RYAN) (Q3 2026) Earnings Call Highlights: Revenue Growth

Ryan Specialty Holdings (RYAN) reported Q3 2026 revenue growth slowing to 4% from 15% YoY, with adjusted EBITDAC margin down 30 bps to 30.9%. The company cited market challenges, including property pricing declines and increased competition. Management expects continued pressure in Q4 2026 and 2027, with modest margin expansion anticipated. They also discussed growth opportunities in reinsurance and AI-related risks, and potential M&A activity in 2027.

Med

Ryan Specialty grows revenue as property softening squeezes E&S returns

Ryan Specialty reported a 4.7% revenue increase to $790M in Q3 2026, driven by casualty lines, while property revenue declined. Underwriting management grew 5.4%, expanding its share of total revenue. Expenses rose 9.9%, outpacing revenue growth. The company maintained its full-year guidance for mid-single-digit organic revenue growth and reported a 3.8% increase in adjusted EBITDAC to $244.4M.